T. Rowe Price Health Care ETF (TMED)
NASDAQ: TMED · Real-Time Price · USD
34.16
+0.96 (2.88%)
Jun 26, 2026, 4:00 PM EDT - Market closed
2.88% (1D)
| Assets | $22.20M |
| Expense Ratio | 0.44% |
| PE Ratio | 27.82 |
| Shares Out | 675,000 |
| Dividend (ttm) | $0.16 |
| Dividend Yield | 0.47% |
| Ex-Dividend Date | Dec 23, 2025 |
| Payout Ratio | 13.16% |
| 1-Year Return | +38.30% |
| Volume | 1,123 |
| Open | 33.74 |
| Previous Close | 33.20 |
| Day's Range | 33.59 - 34.16 |
| 52-Week Low | 23.46 |
| 52-Week High | 34.16 |
| Beta | n/a |
| Holdings | 105 |
| Inception Date | Jun 11, 2025 |
About TMED
Fund Home PageThe T. Rowe Price Health Care ETF (TMED) is an exchange-traded fund. The ETF currently has 21.41m in AUM and 102 holdings. TMED is an actively managed ETF, aiming to outperform its respective sector index TMED was launched on Jun 11, 2025 and is issued by T. Rowe Price.
Asset Class Equity
Category Health
Stock Exchange NASDAQ
Ticker Symbol TMED
ETF Provider T. Rowe Price
Top 10 Holdings
47.95% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 16.46% |
| UnitedHealth Group Incorporated | UNH | 7.03% |
| Gilead Sciences, Inc. | GILD | 4.57% |
| Thermo Fisher Scientific Inc. | TMO | 4.21% |
| Danaher Corporation | DHR | 3.06% |
| Agilent Technologies, Inc. | A | 2.70% |
| Alnylam Pharmaceuticals, Inc. | ALNY | 2.64% |
| Intuitive Surgical, Inc. | ISRG | 2.56% |
| Insulet Corporation | PODD | 2.42% |
| Stryker Corporation | SYK | 2.30% |
News
When Eli Lilly Pivots, TMED's Strategy Wins
The T. Rowe Price Health Care ETF (TMED) led all T. Rowe Price funds last week, posting a 3.4% return.
4 weeks ago - ETF Trends
T. ROWE PRICE ADDS THREE NEW TRANSPARENT SECTOR OFFERINGS TO ITS ACTIVE ETF ROSTER
BALTIMORE, June 12, 2025 /PRNewswire/ -- T. Rowe Price (NASDAQ-GS: TROW), a global investment management firm, announced today the addition of three new active transparent equity exchange-traded funds...
1 year ago - PRNewsWire